Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Celularity (CELU) EBIAT (2020 - 2025)

Celularity has reported EBIAT over the past 6 years, most recently at -$24.4 million for Q4 2025.

  • Quarterly EBIAT rose 15.45% to -$24.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$81.5 million through Dec 2025, down 18.45% year-over-year, with the annual reading at -$91.7 million for FY2025, 58.43% down from the prior year.
  • EBIAT was -$24.4 million for Q4 2025 at Celularity, down from -$12.9 million in the prior quarter.
  • Over five years, EBIAT peaked at $47.8 million in Q2 2022 and troughed at -$93.9 million in Q3 2023.
  • The 5-year median for EBIAT is -$20.9 million (2024), against an average of -$21.2 million.
  • Year-over-year, EBIAT skyrocketed 704.8% in 2022 and then crashed 1562.7% in 2023.
  • A 5-year view of EBIAT shows it stood at -$4.0 million in 2021, then skyrocketed by 704.8% to $24.4 million in 2022, then plummeted by 60.93% to $9.5 million in 2023, then plummeted by 401.81% to -$28.8 million in 2024, then rose by 15.45% to -$24.4 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's EBIAT are -$24.4 million (Q4 2025), -$12.9 million (Q3 2025), and -$24.5 million (Q2 2025).